Global Spinal Cord Stimulation (SCS) Devices Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

A Spinal Cord Stimulator (SCS) or Dorsal Column Stimulator (DCS) is a type of implantable neuromodulation device (sometimes called a "pain pacemaker") that is used to send electrical signals to select areas of the spinal cord (dorsal columns) for the treatment of certain pain conditions. SCS is a consideration for people who have a pain condition that has not responded to more conservative therapy.
The classification of spinal cord stimulation devices includes rechargeable type and non-rechargeable type. The proportion of rechargeable type in 2019 is about 69%, and the proportion is in increasing trend from 2015 to 2019.
Spinal cord stimulation devices are widely used in Hospitals and Ambulatory Surgery Centers. The most proportion of spinal cord stimulation devices is used in Hospitals, and the proportion in 2019 is 71%.
North America is the largest consumption place, with a consumption market share nearly 57.7% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 24%.
Market competition is intense. Medtronic, Boston Scientific, Abbott (St. Jude Medical), Nevro, Nuvectra are the leaders of the industry. And top 3 account for around 79% of the total market share. These existing companies are making investments in several research activities to launch new devices.

In 2020, the global Spinal Cord Stimulation (SCS) Devices market size was US$ 2508.5 million and is forecast to 3680.9 million US in 2027, growing at a CAGR of 6.6% during the 2021-2027. In this study, 2020 has been considered as the base year and 2021 to 2027 as the forecast period to estimate the market size for Spinal Cord Stimulation (SCS) Devices.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Spinal Cord Stimulation (SCS) Devices market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Spinal Cord Stimulation (SCS) Devices market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Spinal Cord Stimulation (SCS) Devices market. Readers of the report can become informed about current and future trends of the global Spinal Cord Stimulation (SCS) Devices market and how they will impact market growth during the forecast period.

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Segment by Type
Rechargeable SCS
Non-Rechargeable SCS

Segment by Application
Hospitals
Ambulatory Surgery Centers

By Company
Medtronic
Boston Scientific
Abbott (St. Jude Medical)
Nevro
Nuvectra